Detalhe da pesquisa
1.
Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice.
Int J Mol Sci
; 24(13)2023 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37446253
2.
PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1+ and CD8+ tumor-infiltrating T cells and outcome.
Mod Pathol
; 29(12): 1552-1564, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27562497
3.
Immunohistochemistry as a potential tool for routine detection of the NRAS Q61R mutation in patients with metastatic melanoma.
J Am Acad Dermatol
; 72(5): 786-93, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25659223
4.
[Accreditation of the activity of molecular pathology according to ISO 15189: key steps to follow and the main potential pitfalls]. / Accréditation de l'activité de pathologie moléculaire selon la norme ISO 15189. Principales étapes à respecter et principaux écueils possibles.
Ann Pathol
; 33(1): 12-23, 2013 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-23472892
5.
[The accreditation of a surgical pathology and somatic genetic laboratory (LPCE, CHU of Nice) according to the ISO 15189 norm: Sharing of experience]. / L'accréditation selon la norme ISO 15189 d'un laboratoire de pathologie et de génétique somatique (LPCE, CHU de Nice) : retour d'expérience.
Ann Pathol
; 33(6): 386-97, 2013 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-24331720
6.
[Setting up a department of molecular pathology in oncology in a pathology laboratory (LPCE, CHU de Nice)]. / Mise en place d'un secteur de pathologie moléculaire en oncologie au sein d'un laboratoire d'anatomie pathologique (LPCE, CHU de Nice).
Ann Pathol
; 33(1): 24-37, 2013 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-23472893
7.
Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank.
Cancers (Basel)
; 15(8)2023 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190299
8.
Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort.
Pathology
; 55(7): 929-944, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37863710
9.
Lack of correlation between MET and PD-L1 expression in non-small cell lung cancer revealed by comparative study of matched biopsies and surgical resection samples.
Lung Cancer
; 181: 107230, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37150140
10.
Analytical validation of automated multiplex chromogenic immunohistochemistry for diagnostic and predictive purpose in non-small cell lung cancer.
Lung Cancer
; 166: 1-8, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134710
11.
Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes.
Diagnostics (Basel)
; 12(3)2022 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35328303
12.
Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System.
Front Pharmacol
; 12: 657743, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33935776
13.
Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France).
Cancers (Basel)
; 12(4)2020 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294880
14.
In-house Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-small Cell Lung Cancer and Melanoma Patients.
Cancers (Basel)
; 11(9)2019 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31470674
15.
Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients.
J Thorac Oncol
; 14(7): 1204-1212, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30999109
16.
Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients.
Lung Cancer
; 121: 70-75, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29858030